Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.3%

136 terminated/withdrawn out of 1320 trials

Success Rate

84.6%

-2.0% vs industry average

Late-Stage Pipeline

13%

165 trials in Phase 3/4

Results Transparency

46%

341 of 745 completed trials have results

Key Signals

178 recruiting341 with results77 terminated59 withdrawn

Enrollment Performance

Analytics

N/A

655(60.0%)

Phase 2

150(13.7%)

Phase 4

119(10.9%)

Phase 1

98(9.0%)

Phase 3

46(4.2%)

Early Phase 1

24(2.2%)

1092Total

N/A(655)

Phase 2(150)

Phase 4(119)

Phase 1(98)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1320)

Showing 20 of 1320 trials

NCT02490527Not ApplicableCompleted

Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity

Role: lead

NCT05913687Active Not Recruiting

Automated Imaging Differentiation of Parkinsonism

Role: collaborator

NCT02425345Not ApplicableCompleted

Women's Health Initiative Strong and Healthy Study

Role: collaborator

NCT07173803Phase 2Not Yet Recruiting

The Progressive Supranuclear Palsy Clinical Trial Platform

Role: collaborator

NCT04057339Not ApplicableCompleted

The Influence of Time-Restricted Eating in Patients With Metabolic Syndrome

Role: lead

NCT06710223Phase 1Active Not Recruiting

Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab

Role: lead

NCT06125509Completed

SHARE Project Define

Role: collaborator

NCT06624475Phase 2Recruiting

Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma

Role: lead

NCT07729046Phase 2Not Yet Recruiting

Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer

Role: lead

NCT07052721Not ApplicableCompleted

Randomized Study of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Shoulder/Foot Surgery

Role: lead

NCT07725250Not ApplicableRecruiting

Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial

Role: collaborator

NCT06362824Not ApplicableRecruiting

Promoting Physical Activity in Older Hispanic/Latino(a) Adults

Role: collaborator

NCT06814522Phase 1Recruiting

Psilocybin-Assisted Therapy for Physician Well-Being and Burnout

Role: lead

NCT07713940Not ApplicableRecruiting

Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous

Role: lead

NCT07693270Recruiting

Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery

Role: lead

NCT06005012Phase 2Active Not Recruiting

Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

Role: lead

NCT05787639Phase 2Active Not Recruiting

Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)

Role: lead

NCT07706595Not ApplicableEnrolling By Invitation

A Randomized Controlled Trial Comparing Posterior Nasal Nerve Ablation Procedures for Chronic Rhinitis

Role: lead

NCT07693543Phase 2Not Yet Recruiting

Nicotinamide Riboside Supplementation in Chronic Kidney Disease

Role: lead

NCT06124339Not ApplicableActive Not Recruiting

Brain Health Virtual Reality Study

Role: lead